Rhenman & Partners Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-130,000
Closed -$6.47M 99
2017
Q3
$6.47M Sell
130,000
-30,000
-19% -$1.45M 0.83% 49
2017
Q2
$7.67M Buy
+160,000
New +$7.65M 1.1% 33

Other funds holding SNY

Rhenman & Partners Asset Management's SNY Position: Q4 2017 in Review

Rhenman & Partners Asset Management sold out of Sanofi (SNY) in Q4 2017, closing a stake of 130,000 shares — an estimated $6.47M sold.

Rhenman & Partners Asset Management first reported a position in SNY in Q2 2017 and held it in 2 quarters. The position peaked at $7.67M in Q2 2017. 504 funds tracked by Wall St. Rank hold SNY as of Q4 2017.

  • Rhenman & Partners Asset Management reported no remaining Sanofi position as of Q4 2017 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 130,000 Sanofi shares in Q4 2017, an estimated $6.47M.
  • Rhenman & Partners Asset Management first reported a position in Sanofi in Q2 2017 and held it in 2 quarters.
  • Rhenman & Partners Asset Management's Sanofi position peaked at $7.67M in Q2 2017.
  • 504 funds tracked by Wall St. Rank held Sanofi as of Q4 2017.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2017, filed 19 Jan 2018.